1. Home
  2. TTD vs NTRA Comparison

TTD vs NTRA Comparison

Compare TTD & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTD
  • NTRA
  • Stock Information
  • Founded
  • TTD 2009
  • NTRA 2003
  • Country
  • TTD United States
  • NTRA United States
  • Employees
  • TTD N/A
  • NTRA N/A
  • Industry
  • TTD Computer Software: Programming Data Processing
  • NTRA Medical Specialities
  • Sector
  • TTD Technology
  • NTRA Health Care
  • Exchange
  • TTD Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • TTD 25.2B
  • NTRA 24.9B
  • IPO Year
  • TTD 2016
  • NTRA 2015
  • Fundamental
  • Price
  • TTD $53.12
  • NTRA $168.81
  • Analyst Decision
  • TTD Buy
  • NTRA Strong Buy
  • Analyst Count
  • TTD 35
  • NTRA 17
  • Target Price
  • TTD $88.18
  • NTRA $192.41
  • AVG Volume (30 Days)
  • TTD 21.4M
  • NTRA 1.1M
  • Earning Date
  • TTD 11-06-2025
  • NTRA 11-11-2025
  • Dividend Yield
  • TTD N/A
  • NTRA N/A
  • EPS Growth
  • TTD 62.73
  • NTRA N/A
  • EPS
  • TTD 0.83
  • NTRA N/A
  • Revenue
  • TTD $2,679,088,000.00
  • NTRA $1,964,250,000.00
  • Revenue This Year
  • TTD $18.17
  • NTRA $24.28
  • Revenue Next Year
  • TTD $16.51
  • NTRA $15.22
  • P/E Ratio
  • TTD $64.47
  • NTRA N/A
  • Revenue Growth
  • TTD 23.18
  • NTRA 44.38
  • 52 Week Low
  • TTD $42.96
  • NTRA $117.27
  • 52 Week High
  • TTD $141.53
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • TTD 57.92
  • NTRA 55.73
  • Support Level
  • TTD $48.14
  • NTRA $157.43
  • Resistance Level
  • TTD $50.74
  • NTRA $164.88
  • Average True Range (ATR)
  • TTD 1.98
  • NTRA 5.38
  • MACD
  • TTD 1.44
  • NTRA -0.66
  • Stochastic Oscillator
  • TTD 94.41
  • NTRA 50.42

About TTD The Trade Desk Inc.

The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: